Zacks Research Issues Optimistic Forecast for A Earnings

Agilent Technologies, Inc. (NYSE:A) – Equities research analysts at Zacks Research lifted their Q1 2026 EPS estimates for Agilent Technologies in a research note issued to investors on Wednesday, March 19th. Zacks Research analyst R. Department now forecasts that the medical research company will post earnings of $1.39 per share for the quarter, up from their prior estimate of $1.35. The consensus estimate for Agilent Technologies’ current full-year earnings is $5.57 per share. Zacks Research also issued estimates for Agilent Technologies’ Q2 2026 earnings at $1.47 EPS.

Several other research analysts have also commented on A. Robert W. Baird lowered their price objective on shares of Agilent Technologies from $161.00 to $159.00 and set an “outperform” rating for the company in a research note on Thursday, February 27th. StockNews.com raised Agilent Technologies from a “hold” rating to a “buy” rating in a report on Tuesday, December 24th. Bank of America cut their target price on shares of Agilent Technologies from $153.00 to $150.00 and set a “neutral” rating on the stock in a report on Friday, December 13th. Sanford C. Bernstein reduced their price objective on Agilent Technologies from $140.00 to $135.00 and set a “market perform” rating for the company in a research note on Tuesday, November 26th. Finally, JPMorgan Chase & Co. reduced their target price on shares of Agilent Technologies from $165.00 to $160.00 and set an “overweight” rating for the company in a research note on Tuesday, November 26th. Seven research analysts have rated the stock with a hold rating and eight have given a buy rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $146.15.

Agilent Technologies Trading Up 1.0 %

NYSE A opened at $121.96 on Monday. Agilent Technologies has a 12 month low of $117.17 and a 12 month high of $155.35. The stock has a market capitalization of $34.77 billion, a P/E ratio of 28.04, a PEG ratio of 3.39 and a beta of 1.11. The firm’s 50-day moving average is $136.34 and its two-hundred day moving average is $137.16. The company has a debt-to-equity ratio of 0.56, a current ratio of 2.20 and a quick ratio of 1.66.

Agilent Technologies (NYSE:A) last posted its quarterly earnings results on Wednesday, February 26th. The medical research company reported $1.31 earnings per share for the quarter, beating the consensus estimate of $1.27 by $0.04. The business had revenue of $1.68 billion during the quarter, compared to analysts’ expectations of $1.67 billion. Agilent Technologies had a net margin of 19.27% and a return on equity of 25.56%.

Agilent Technologies Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, April 23rd. Shareholders of record on Tuesday, April 1st will be issued a $0.248 dividend. The ex-dividend date is Tuesday, April 1st. This represents a $0.99 dividend on an annualized basis and a yield of 0.81%. Agilent Technologies’s dividend payout ratio (DPR) is 22.76%.

Insider Activity at Agilent Technologies

In other Agilent Technologies news, VP Rodney Gonsalves sold 1,908 shares of the business’s stock in a transaction dated Monday, March 17th. The stock was sold at an average price of $121.98, for a total transaction of $232,737.84. Following the transaction, the vice president now owns 21,786 shares in the company, valued at $2,657,456.28. The trade was a 8.05 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CEO Padraig Mcdonnell sold 1,911 shares of the stock in a transaction that occurred on Tuesday, January 21st. The shares were sold at an average price of $150.00, for a total transaction of $286,650.00. Following the completion of the sale, the chief executive officer now directly owns 39,652 shares of the company’s stock, valued at $5,947,800. This trade represents a 4.60 % decrease in their position. The disclosure for this sale can be found here. Insiders own 0.26% of the company’s stock.

Institutional Trading of Agilent Technologies

Several institutional investors have recently added to or reduced their stakes in A. 111 Capital bought a new position in shares of Agilent Technologies in the 4th quarter worth about $668,000. Wealth Enhancement Advisory Services LLC boosted its stake in Agilent Technologies by 32.9% during the fourth quarter. Wealth Enhancement Advisory Services LLC now owns 27,563 shares of the medical research company’s stock valued at $3,703,000 after buying an additional 6,828 shares in the last quarter. Lansforsakringar Fondforvaltning AB publ bought a new position in shares of Agilent Technologies during the 4th quarter valued at about $12,804,000. PKO Investment Management Joint Stock Co acquired a new position in Agilent Technologies in the fourth quarter worth approximately $484,000. Finally, Wood Tarver Financial Group LLC acquired a new position in shares of Agilent Technologies in the 4th quarter worth $34,000. 87.42% of the stock is owned by institutional investors and hedge funds.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.